I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 13 studies | 56% ± 13% | |
| conventional dendritic cell | 11 studies | 28% ± 13% | |
| regulatory T cell | 11 studies | 23% ± 5% | |
| classical monocyte | 7 studies | 24% ± 7% | |
| dendritic cell | 7 studies | 30% ± 8% | |
| macrophage | 7 studies | 18% ± 4% | |
| non-classical monocyte | 6 studies | 26% ± 8% | |
| natural killer cell | 5 studies | 19% ± 5% | |
| B cell | 5 studies | 23% ± 5% | |
| memory B cell | 4 studies | 18% ± 1% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 20% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 18% ± 3% | |
| mucosal invariant T cell | 3 studies | 18% ± 1% | |
| naive B cell | 3 studies | 18% ± 2% | |
| myeloid cell | 3 studies | 19% ± 3% |
